Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 2
1989 1
1990 1
1996 1
2009 1
2015 1
2017 5
2018 3
2019 3
2020 24
2021 53
2022 34
2023 14
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

108 results

Results by year

Filters applied: . Clear all
Page 1
Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis.
Wenzel M, Nocera L, Collà Ruvolo C, Würnschimmel C, Tian Z, Shariat SF, Saad F, Tilki D, Graefen M, Kluth LA, Briganti A, Mandel P, Montorsi F, Chun FKH, Karakiewicz PI. Wenzel M, et al. Among authors: nocera l. Prostate Cancer Prostatic Dis. 2022 Feb;25(2):139-148. doi: 10.1038/s41391-021-00395-4. Epub 2021 May 30. Prostate Cancer Prostatic Dis. 2022. PMID: 34054128 Free PMC article. Review.
Chemotherapy and advanced androgen blockage, alone or combined, for metastatic hormone-sensitive prostate cancer a systematic review and meta-analysis.
Fallara G, Robesti D, Nocera L, Raggi D, Marandino L, Belladelli F, Montorsi F, Malavaud B, Ploussard G, Necchi A, Martini A. Fallara G, et al. Among authors: nocera l. Cancer Treat Rev. 2022 Nov;110:102441. doi: 10.1016/j.ctrv.2022.102441. Epub 2022 Jul 26. Cancer Treat Rev. 2022. PMID: 35939976 Review.
Neoadjuvant Pembrolizumab and Radical Cystectomy in Patients with Muscle-Invasive Urothelial Bladder Cancer: 3-Year Median Follow-Up Update of PURE-01 Trial.
Basile G, Bandini M, Gibb EA, Ross JS, Raggi D, Marandino L, Costa de Padua T, Crupi E, Colombo R, Colecchia M, Lucianò R, Nocera L, Moschini M, Briganti A, Montorsi F, Necchi A. Basile G, et al. Among authors: nocera l. Clin Cancer Res. 2022 Dec 1;28(23):5107-5114. doi: 10.1158/1078-0432.CCR-22-2158. Clin Cancer Res. 2022. PMID: 36190522 Clinical Trial.
Reply by Authors.
Wenzel M, Nocera L, Collà Ruvolo C, Würnschimmel C, Tian Z, Shariat SF, Saad F, Briganti A, Tilki D, Graefen M, Kluth LA, Mandel P, Chun FKH, Karakiewicz PI. Wenzel M, et al. Among authors: nocera l. J Urol. 2021 Jul;206(1):79. doi: 10.1097/JU.0000000000001695.03. Epub 2021 Apr 6. J Urol. 2021. PMID: 33820427 No abstract available.
An external validation of the nocera nomogram: Predicting non-organ confined stage of ≥pT3 in cT1 clear cell renal cell carcinoma.
Wenzel M, Hoeh B, Rührup J, Gambetta H, Nocera L, Würnschimmel C, Tian Z, Karakiewicz PI, Briganti A, Chun FKH, Roos FC, Becker A, Krimphove MJ. Wenzel M, et al. Among authors: nocera l. Front Oncol. 2022 Oct 10;12:1019057. doi: 10.3389/fonc.2022.1019057. eCollection 2022. Front Oncol. 2022. PMID: 36300101 Free PMC article.
Pembrolizumab in advanced renal cell carcinoma: a meta-analysis providing level 1a evidence.
Capitanio U, Fallara G, Raggi D, Nocera L, Larcher A, Belladelli F, Rowe I, Briganti A MD,PhD, Salonia A MD,PhD, Karakiewicz P, Montorsi F, Martini A, Necchi A. Capitanio U, et al. Among authors: nocera l. Curr Probl Cancer. 2022 Aug;46(4):100875. doi: 10.1016/j.currproblcancer.2022.100875. Epub 2022 Jun 1. Curr Probl Cancer. 2022. PMID: 35679628 Review.
Nerve-sparing robot-assisted radical prostatectomy with the HUGO™ robot-assisted surgery system using the 'Aalst technique'.
Paciotti M, Bravi CA, Mottaran A, Nocera L, Sarchi L, Piro A, Farinha R, Peraire Lores M, Balestrazzi E, Piramide F, Roussel E, De Backer P, D'Hondt F, De Naeyer G, De Groote R, Mottrie A. Paciotti M, et al. Among authors: nocera l. BJU Int. 2023 Aug;132(2):227-230. doi: 10.1111/bju.16084. Epub 2023 Jun 2. BJU Int. 2023. PMID: 37269137 No abstract available.
10-Year Outcomes in Localized Prostate Cancer.
Nocera L, Karabon P, Abdollah F. Nocera L, et al. N Engl J Med. 2017 Jan 12;376(2):178-9. doi: 10.1056/NEJMc1614342. N Engl J Med. 2017. PMID: 28079331 No abstract available.
108 results